BTZ alone or in combination with NK cells did not further decrease GBM mitochondrial function compared to NK cell monotherapy (Supplementary Figure S1H–M), confirming NK cells’ potent role in GBM cell lysis. The gene discussed is CASC3; the disease is glioblastoma.